News 2014-09-12
2014 Semi-Annual & OD project summary conference
The conference of 2014 semi-annual and OD project summary was held on Aug. 31st to Sep. 2nd 2014 at Jin Fo Shan in Nanshuan District.
During the meeting, we summarized the progress of “Three Battles (BPM, GMP and KAM)”which were confirmed at the beginning of this year. We also concluded and analyzed the performance of each economic indicator in H1 of 2014.
The redefined core values and its connotations were officially published on Sep. 1st, 2014, and thus determined the concept of Porton culture on its mission, vision and core values.
Others
More
News 2024-10-31
Milestone | Comprehensive Enhancement of GMP Manufacturing Capacity and New Modality Service Capabilities at Porton Fengxian, Shanghai
Recently, Porton Pharma has achieved a significant capacity breakthrough at its GMP manufacturing facility in Fengxian, Shanghai, China, further enhancing its production capabilities and technological strength in new modality areas such as peptide and oligonucleotide drugs. This upgrade represents an important step in Porton's commitment to becoming a leading global CDMO company.
News 2024-10-24
Porton Pharma Solutions Signed Strategic Partnership with Shanghai InnoStar
On October 24, 2024, Porton Pharma SolutionsLtd. ("Porton") announced a strategic partnership with Shanghai InnoStar Bio-tech Co., Ltd. ("InnoStar") in Shanghai. The distinguished signing ceremony was attended by Mr. Ju Nianfeng, Chairman and CEO of Porton; Dr. Chang Yan, President of InnoStar; Ms. Pi Wei, Deputy General Manager of Porton; Ms. Fan Meng, Deputy General Manager of the Sales & Marketing Center, Dr. Fang Xin, Senior Director of Non-clinicalPharmacology BU at InnoStar, and Ms. Zhao Jie, Marketing Associate Director at InnoStar.
